Cahyono, Agus and Irwanto, Irwanto and Rahman, Mahrus Abdur and Widjiati, Widjiati (2026) Sildenafil and metformin combination attenuates monocrotaline- induced pulmonary hypertension via TNF-α and ERK1/2 modulation. Journal of Pharmacy & Pharmacognosy Research (JPPRes), 14 (01). p. 2507. ISSN 0719-4250
|
PDF
jppres_14.1.2507.pdf Download (924kB) |
Abstract
Context: Pediatric pulmonary hypertension (PH) is associated with poor outcomes and limited US-approved pharmacotherapies. Aims: To evaluate the effects of sildenafil, metformin, and their combination on hemodynamics, inflammatory mediators, and vascular remodeling in monocrotaline (MCT)-induced PH. Methods: Male Wistar rats received MCT (60 mg/kg, s.c.). Beginning 24 h later, animals were assigned to MCT-control, sildenafil (5 mg/kg), metformin (100 mg/kg), or combined therapy for 21 days. On day 22, right-heart catheterization was performed. Serum TNF-α and ERK1/2 were measured by ELISA, and pulmonary arterial remodeling was assessed by HE and α-SMA staining with intima-media thickness measurements. Results: Relative to MCT-control, all treatments lowered mPAP; the combination group exhibited the most considerable reductions in TNF-α and ERK1/2, and a partial reduction in intima-media thickness. Conclusions: Sildenafil and metformin, particularly in combination, improved pulmonary hemodynamics and attenuated inflammation in MCT-PH. Confirmation in lung tissue (e.g., p-ERK1/2) and cell-specific analyses is warranted.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | extracellular signal-regulated kinase; metformin; monocrotaline; pulmonary hypertension; sildenafil; tumor necrosis factor-α. |
| Subjects: | R Medicine > R Medicine (General) |
| Divisions: | Faculty of Medical |
| Depositing User: | BAMBANG SEPTIAWAN |
| Date Deposited: | 27 Jan 2026 02:52 |
| Last Modified: | 27 Jan 2026 02:52 |
| URI: | http://repository.ubaya.ac.id/id/eprint/50197 |
Actions (login required)
![]() |
View Item |
